demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 hospitalized
COVID-19 mild to moderate
antiandrogenic
progesterone Ghandehari

1 studies excluded by filtering options 1

6487 Lazzeri, 2021 0130selection pending